深度学习算法检测多发性骨髓瘤CT溶骨性病变
本研究开发了一种两步深度学习模型,用于在全身低剂量CT上检测多发性骨髓瘤的溶骨性病变。模型在测试集上达到91.6%的敏感度和84.6%的特异度,AUROC为90.4%。作者认为该模型性能较高,但需外部验证后才能广泛用于临床。
要点
- 全身低剂量CT是评估骨髓瘤骨破坏的推荐初始影像方法。
- 深度学习模型检测溶骨性病变敏感度91.6%、特异度84.6%。
- 病变检测AUROC达90.4%,但需外部验证后用于临床。
英文原文(摘要)· 点击展开
BACKGROUND: Whole-body low-dose CT is the recommended initial imaging modality to evaluate bone destruction as a result of multiple myeloma. Accurate interpretation of these scans to detect small lytic bone lesions is time intensive. A functional deep learning) algorithm to detect lytic lesions on CTs could improve the value of these CTs for myeloma imaging. Our objectives were to develop a DL algorithm and determine its performance at detecting lytic lesions of multiple myeloma.
METHODS: Axial slices (2-mm section thickness) from whole-body low-dose CT scans of subjects with biochemically confirmed plasma cell dyscrasias were included in the study. Data were split into train and test sets at the patient level targeting a 90%/10% split. Two musculoskeletal radiologists annotated lytic lesions on the images with bounding boxes. Subsequently, we developed a two-step deep learning model comprising bone segmentation followed by lesion detection. Unet and "You Look Only Once" (YOLO) models were used as bone segmentation and lesion detection algorithms, respectively. Diagnostic performance was determined using the area under the receiver operating characteristic curve (AUROC).
RESULTS: Forty whole-body low-dose CTs from 40 subjects yielded 2193 image slices. A total of 5640 lytic lesions were annotated. The two-step model achieved a sensitivity of 91.6% and a specificity of 84.6%. Lesion detection AUROC was 90.4%.
CONCLUSION: We developed a deep learning model that detects lytic bone lesions of multiple myeloma on whole-body low-dose CTs with high performance. External validation is required prior to widespread adoption in clinical practice.
引用
- Faghani, Baffour, Ringler, et al. A deep learning algorithm for detecting lytic bone lesions of multiple myeloma on CT. Skeletal Radiol. 2022. PMID: 35980454. doi:10.1007/s00256-022-04160-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。